Systematic review and meta-analysis of anakinra, sarilumab, siltuximab and tocilizumab for COVID-19. (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/thoraxjnl-2020-215266
PubMed Identifier: 33579777
Publication URI: http://europepmc.org/abstract/MED/33579777
Type: Systematic review
Volume: 76
Parent Publication: Thorax
Issue: 9
ISSN: 0040-6376